Cardiovascular Endocrinology

A combination of conditions that together increase the risk of Cardiovascular Disease (CVD). Increase in worldwide prevalence of obesity-associated diabetes, dyslipidemia and hypertension makes it imperative that endocrinologists, cardiologists and others have a forum for new treatment and therapeutic developments. Patients with diabetes are at increased risk of developing a number of serious microvascular and macrovascular complications. Across all ages, the relative risk of developing cardiovascular disease (CVD) is ∼2 for patients with diabetes compared with the general population and CVD contributes significantly to the increased, albeit decreasing over time, mortality rate. Still, CVD accounts for up to 50% of deaths in patients with diabetes. The American Heart Association (AHA) predicts that by 2030, 40.5% of the US population will likely have some form of a CVD, and that the direct cost of treating CVDs will triple from $273 billion in 2010 to $818 billion in 2030; with indirect costs expected to increase from $172 billion to $276 billion in the same time period. These statistics are significant because Americans are developing diabetes and CVD at much younger ages than ever, due to overweight or obesity. Metabolic syndrome doubles the risk of CVD and quintuples the diabetes risk. Risk is especially high in men older than age 45 and women older than age 55.

    Related Conference of Cardiovascular Endocrinology

    October 30-31, 2020

    Annual Summit on Metabolomics

    Vancouver, Canada
    November 09-10, 2020

    International Congress and Expo on Diabetic Care

    Bangkok, Thailand
    November 13-14, 2020

    International Conference on Diabetes and Heart Diseases

    Bangkok, Thailand
    November 16-17, 2020

    World Congress and Expo on Diabetes

    Kyoto, Japan
    November 16-17, 2020

    2nd Asia Pacific Diabetes and Endocrinology Congress

    Brisbane, Australia
    November 18-19, 2020

    Annual congress on Diabetes and Endocrinology Congress

    Bangkok, Thailand
    December 07-08, 2020

    13th World Congress on Endocrinology and Metabolic Disorders

    Auckland, Newzealand
    February 08-09, 2021

    Global summit on Diabetes and Endocrinology

    London, UK
    March 17-18, 2021

    30th European Diabetes Congress

    Barcelona, Spain
    May 10-11, 2021

    30th World Diabetes & Heart Congress

    Singapore, Singapore
    September 02-03, 2021

    5th Annual Congress on Diabetes, Obesity and Its Complications

    Vienna, Australia
    October 18-19, 2021

    2nd Annual Summit on Diabetes and Endocrinology

    Paris, France

    Cardiovascular Endocrinology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in